Position in IBRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,011,825
+$1,961,204 QoQ
Shares Held
262,298
+1827.5% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtu Financial LLC holds $51,538,389 across 141 Biotechnology names. IBRX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
70,715 | $3,728,094 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,634 | $3,408,886 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
67,775 | $2,692,023 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
54,785 | $2,204,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,479 | $2,173,678 | |
| 6 | IBRX |
ImmunityBio, Inc.
This page
|
262,298 | $2,011,825 | |
| 7 | KALA |
KALA BIO, Inc.
|
152,197 | $1,316,504 | |
| 8 | IMUX |
Immunic, Inc.
|
113,366 | $1,258,362 |
All Filings in IBRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,011,825 | 262,298 | Shares | Defined | 2026-05-14 | |
| 2024-09-30 | $50,621 | 13,608 | Shares | Defined | 2024-11-20 | |
| 2024-03-31 | $60,600 | 11,285 | Shares | Defined | 2024-05-20 | |
| 2023-12-31 | $303,554 | 60,469 | Shares | Defined | 2024-02-26 | |
| 2022-03-31 | $73,995 | 13,190 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $183,920 | 30,250 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $196,036 | 20,127 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $526,909 | 22,195 | Shares | Defined | 2021-05-19 | |
| No filing history on record for this holder in this stock. | ||||||